Iffat Prianka | Public Health | Best Researcher Award

Assist. Prof. Dr. Iffat Prianka | Public Health | Best Researcher Award

Assist. Prof. Dr. Iffat Prianka | Ibrahim Medical College | Bangladesh

Dr. Iffat Tania Prianka is an accomplished public health researcher and academic with extensive experience in community medicine, preventive and social medicine, and epidemiology. She holds an M. Phil. in Preventive and Social Medicine and an MPH in Epidemiology, and is currently pursuing a PhD. Her academic contributions include research on autism awareness among medical students, internet addiction, physical exercise practices among diabetic patients, and mental stress in infertile women. Dr. Prianka has served in diverse roles including Lecturer and Assistant Professor at Ibrahim Medical College, Senior House Physician at United Hospital Dhaka, and Lead Medical Officer and Public Health Expert at Fera Foundation, USA. She has significant experience in research methodology, data analysis, manuscript preparation, and public health program implementation. Her professional development includes international training in medical education, research methodology, data interpretation, and faculty development programs. She has presented at international conferences, received awards for academic excellence, and published multiple peer-reviewed research articles in reputable journals. Dr. Prianka is proficient in statistical software (SPSS, STATA) and skilled in scientific communication, teaching, and community health research.

Profile: Orcid

Featured Publications

Prianka, I. T., Haque, W., Jahan, N., Saha, M., Prity, T. T., & Gupta, P. K. S. (2022). Knowledge and attitude on early sign of autism among 1st year to 3rd year medical students in a selected medical college in Bangladesh. International Journal of Medical Research and Pharmaceuticals, 9(9).

Jahan, N., Idris, M. R., Prianka, I. T., & Gupta, P. K. S. (2022). Internet addiction and its determinants among medical students in Dhaka City during COVID-19 pandemic. International Journal of Medical Research and Pharmaceuticals, 9(12).

Jenny Gentizon | Public Health | Applied Scientist Award

Dr. Jenny Gentizon | Public Health | Applied Scientist Award

Dr. Jenny Gentizon,  University of Lausanne (UNIL), Switzerland

Dr. Jenny Gentizon is a senior lecturer and head of the Nurse Practitioner Master’s program at the University of Lausanne (UNIL) and Lausanne University Hospital (CHUV) in Switzerland. She holds a PhD in Nursing Sciences and specializes in advanced practice nursing, gerontology, and medication literacy. Her research focuses on improving medication management in older adults and developing tools to support pharmaceutical care. She is actively involved in European nursing science networks and leads educational and clinical initiatives aimed at strengthening the role of advanced practice nurses in the healthcare system.

Author Profile

orcid

🎓 Early Academic Pursuits

Dr. Jenny Gentizon’s journey into nursing science began with a profound interest in patient care and the healthcare system’s evolving complexity. She earned her Bachelor of Science in Nursing Sciences (2003–2007) from the University of Applied Sciences Western Switzerland (HES-SO), Haute École La Source, where her outstanding academic commitment earned her a prize for best dissertation. This early recognition reflected her ability to merge critical thinking with clinical realities—a skill that would define her career. Her academic path continued with a Master of Science in Nursing Sciences (2011–2014), a joint program between UNIL and HES-SO. This phase cemented her interest in evidence-based practice, and her thesis explored the beliefs and attitudes of nurses regarding evidence-based implementation, laying the groundwork for future research. Her pursuit of advanced expertise culminated in a PhD in Nursing Sciences (2017–2022) from the Institute of Higher Education and Research in Healthcare (IUFRS), UNIL/CHUV, where she developed the MED-fLAG—a novel tool to assess medication literacy in older adults. This doctoral work would become a cornerstone of her academic identity.

💼 Professional Endeavors

Dr. Gentizon’s professional path has seamlessly integrated clinical expertise with educational leadership. For over a decade, she served as a Clinical Nurse Specialist (CNS) in geriatric and internal medicine at CHUV, contributing to quality care, coaching, and the supervision of advanced practice nurses. Since 2022, she has held the role of Lecturer and Nurse Researcher at UNIL/CHUV, rising to the position of MER1 sup. (100%) in 2025. As Head of the Nurse Practitioner (NP) Master’s Program, she leads curriculum development, course coordination, and student supervision across several advanced nursing programs. Her teaching portfolio includes subjects such as clinical reasoning, physical examination, and integration of clinical knowledge into practice, demonstrating her holistic approach to nurse education.

🔬 Contributions and Research Focus

Dr. Gentizon’s research bridges the gap between medication safety and gerontological care, focusing on patient empowerment, self-management, and pharmaceutical care. Her PhD work on MED-fLAG led to several peer-reviewed publications and conference presentations, establishing her as a reference in medication literacy among older adults. She has also contributed to studies on fall-risk–increasing drugs (FRIDs), self-efficacy in medication adherence, and the implementation of standardized medication plans in hospital settings. Her projects often take a quasi-experimental or mixed-methods approach, reflecting a rigorous and innovative scientific method. Dr. Gentizon has secured multiple research grants, including funding from the Nursing Science Foundation Switzerland and Fondation CHUV, supporting her interdisciplinary projects on therapeutic education for chronic conditions like psoriasis. Her work consistently emphasizes the role of nurse-led interventions and contributes to reshaping clinical practice through research.

🏆 Accolades and Recognition

Throughout her career, Dr. Gentizon has received numerous accolades for her academic excellence and research impact. Highlights include:

  • Prize for Best Bachelor Dissertation (2007)

  • PhD Research Grant from CHUV (20K CHF)

  • 51K CHF Research Grant from the Nursing Science Foundation Switzerland

  • EANS Scholarship for three summer schools (2018–2021)

She is also a respected peer reviewer for high-impact journals such as the International Journal of Nursing Studies, Journal of Advanced Nursing, BMC Geriatrics, and Palliative and Supportive Care, reflecting her standing in the scientific community.

🌍 Impact and Influence

Dr. Gentizon is an active contributor to national and international nursing networks, including:

  • NuPhaC (Nurse and Pharmaceutical Care) – International board member

  • European Academy of Nursing Science (EANS) – Member

  • Swiss Association for Nursing Science (APSI) – Member

  • Association Engagés pour la Santé – Committee member

She is frequently invited to present at scientific conferences and public forums, where she translates complex research into actionable insights. Her public outreach articles in mainstream media like L’Illustré and INVivo Magazine raise awareness about overmedication, medication literacy, and elderly care, underscoring her commitment to community health education.

🌱 Legacy and Future Contributions

Dr. Gentizon’s legacy lies in her pioneering work on medication literacy and her leadership in advanced practice nursing education. She has supervised over 15 master’s theses and continues to shape future nurse leaders through mentorship and innovative pedagogy.

Her future contributions are likely to focus on:

  • Scaling the implementation of MED-fLAG across healthcare systems

  • Expanding nurse-led intervention models in chronic disease management

  • Advocating for policy changes in advanced practice nursing education

  • Contributing to international collaborative research in gerontology and health literacy

As the healthcare landscape evolves, Dr. Jenny Gentizon stands at the forefront of transforming nursing practice through education, evidence, and empathy. Her commitment to integrating patient-centered care with rigorous scientific inquiry promises a lasting impact on both academia and clinical nursing worldwide.

✍️Notable Publications

Contributors: Jenny Gentizon; Julian Hirt; Cécile Jaques; Pierre-Olivier Lang; Cedric Mabire

Journal: International Journal of Nursing Studies

Year: 2021

Impact of an INtervention to increase MOBility in older hospitalized medical patients (INTOMOB): Study protocol for a cluster randomized controlled trial

Contributors: Blandine Mooser; Dominique Bergsma; Fabian D. Liechti; Christine Baumgartner; Jenny Gentizon; Marie Méan; Maria M. Wertli; Marco Mancinetti; Joachim Schmidt-Leuenberger; Carole Elodie Aubert

Journal: BMC Geriatrics
Year: 2023

Medication Literacy and Medication Self‐Management: A Cross‐Sectional Study in Hospitalised Patients (65+) With Polypharmacy

Contributors: Laura Mortelmans; Jenny Gentizon; Tinne Dilles; Malakeh Malak

Journal: Journal of Nursing Management
Year: 2024

Haishan Jiang | Medical Discoveries | Innovation in Science Award

Dr. Haishan Jiang | Medical Discoveries | Innovation in Science Award 

Dr. Haishan Jiang, Southern Medical University, China

Dr. Haishan Jiang, Chief Physician and Associate Professor at Southern Medical University’s Nanfang Hospital, is a leading expert in neurology, specializing in myopathy, peripheral neuropathy, and rare neurological diseases. As Deputy Director of the Neurology Department and head of the Myopathy and Peripheral Neuropathy subspecialty, he has pioneered gene therapies for SMA and ALS in South China. His research focuses on motor neuron and mitochondrial diseases, as well as gene therapy for rare conditions. Widely recognized, Dr. Jiang has been honored as the “Good Doctor of Guangzhou” and ranks top nationally in physician recommendations for multiple rare diseases.

Author Profile

ORCID

🧑‍🎓 Early Academic Pursuits

Dr. Haishan Jiang embarked on his medical journey with a deep-rooted commitment to understanding the complexities of the human nervous system. With a Doctor of Medicine degree and solid academic grounding, he demonstrated early on a keen interest in neurology, particularly in the areas of myopathy and peripheral neuropathy. His academic path was marked by diligence, a sharp scientific mind, and a profound dedication to uncovering the underlying mechanisms of rare neurological diseases. As a postgraduate supervisor, Dr. Jiang has also shown a strong passion for nurturing the next generation of medical professionals, sharing his knowledge and guiding their research pursuits with patience and precision.

🩺 Professional Endeavors

Currently serving at Nanfang Hospital of Southern Medical University, Dr. Jiang holds several key positions: Chief Physician, Associate Professor, Deputy Director of the Neurology Department, Director of Teaching, and Head of the Myopathy and Peripheral Neuropathy subspecialty. His clinical expertise spans a wide spectrum of neurological disorders, with a particular emphasis on difficult and rare conditions such as motor neuron disease (ALS), mitochondrial encephalomyopathy, and adult-onset spinal muscular atrophy (SMA). Dr. Jiang’s commitment to clinical excellence has led him to establish and lead the Guangdong Province Myopathy and Peripheral Nerve Specialized Alliance, a network aimed at advancing diagnosis, treatment, and research collaboration. Under his leadership, the department ranks among the top two nationally in terms of annual muscle and nerve biopsy volume, solidifying its reputation as a hub for neuromuscular disease care.

🧬 Contributions and Research Focus

Dr. Jiang’s research interests are firmly rooted in neurogenetic disorders, particularly motor neuron diseases (ALS) and mitochondrial disorders. His work seamlessly blends basic science with clinical application, focusing on understanding disease mechanisms and exploring cutting-edge gene therapy approaches. He has spearheaded some of South China’s most advanced gene therapy trials, including the region’s first gene therapy for adult SMA—the fourth such case in the country—and the first ALS gene therapy clinical trial in South China, also the second nationwide. His pioneering research not only contributes to academic knowledge but also offers hope to patients battling previously untreatable conditions. Through his clinical studies, Dr. Jiang is pushing the frontiers of personalized medicine, bringing precision diagnostics and therapy into the mainstream for rare and complex neurological diseases.

🏅 Accolades and Recognition

Dr. Haishan Jiang’s unwavering dedication to medical science and patient care has earned him widespread acclaim. Notably, he was honored as the sixth “Good Doctor of Guangzhou” and selected as part of the ninth batch of “Outstanding Provincial and Municipal Talents Supporting Xinjiang”, a testament to both his clinical excellence and humanitarian spirit. Furthermore, he was recognized by the Good Doctor Network as an “Annual Good Doctor” for his exceptional service in rare disease diagnosis and treatment. His reputation as a leading clinician is reflected in his top rankings in national physician recommendation lists—first place for 13 diseases, including ALS and mitochondrial encephalomyopathy, and second place for 15 others. These accolades not only highlight his expertise but also the trust he has earned from patients and peers alike.

🌍 Impact and Influence

Dr. Jiang’s work has had a transformative impact on neurology in China, particularly in the realm of rare diseases. By advancing the use of gene therapy and establishing regional alliances, he has created a robust infrastructure for collaboration, research, and clinical care. His contributions have significantly improved diagnostic timelines and therapeutic options for patients who previously faced long diagnostic odysseys and limited treatment possibilities. As a teacher and mentor, Dr. Jiang has shaped the careers of countless postgraduate students and young doctors, many of whom now contribute to clinical neurology and research across the country. His influence extends beyond the clinic to policy and advocacy, where he is a strong voice for the rare disease community.

🔬 Legacy and Future Contributions

Dr. Haishan Jiang stands at the forefront of a new era in neurology, where genomics and personalized medicine are reshaping how we understand and treat complex diseases. His legacy is already evident in the systems he has built, the patients he has helped, and the students he has inspired. Looking ahead, Dr. Jiang aims to further expand gene therapy applications, develop innovative treatment protocols, and foster international collaboration in rare disease research. With his continued focus on combining scientific rigor with compassionate care, Dr. Jiang is set to leave a lasting legacy in Chinese and global neurology. His work is not only rewriting the medical narrative for patients with rare conditions but also paving the way for future breakthroughs in neuroscience.

✍️ Publication Top Notes


📘A Multicenter Study of Hereditary Transthyretin Amyloidosis in China

Author: Xujun Chu; Juan Kang; Jingwen Xu; Haishan Jiang; Zhi‐Ying Wu; Qingping Wang; Wei Li; Jia Li;
Journal: Annals of Neurology
Year:2025

📘Knockdown of OPTN modulates miRNA-125b-5p expression via NF-κB pathways in amyotrophic lateral sclerosis

Author: Jian Qin; Ye He; Weiyi Yu; Zhaoyong Zhang; Xiaodan Chen; Yafang Hu; Haishan Jiang
Journal: Archives of Biochemistry and Biophysics
Year: 2025

📘Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China

Author: Yeli Zhu; Jingxian Fan; Xiying Zhu; Wei Li; Zhaoyong Zhang; Hui Zheng; Zhihua Zhou; Lingchao Meng; Ruxu Zhang; Haishan Jiang
Journal: Orphanet Journal of Rare Diseases
Year: 2025